Maintaining CQAs as Manufacturing Processes are Scaled from 2D to 3D Bioreactor Culture February 28, 2022 Biomanufacturing, Quality & Regulatory
Establishing a Working Range for Effective MSC-EV Dose December 16, 2021 Biomanufacturing, Cell Therapy, EVs & Exosomes
Building Effective Multi-Year Process Development Programs II: Evolution of Technology Platform Decisions… March 30, 2021 BioEconomy, Biomanufacturing, Bioprocess Tools, Cell Therapy
Building Effective Multi-Year Process Development Programs I: Estimating hMSC Lot Size Ranges for… March 16, 2021 BioEconomy, Biomanufacturing, Bioprocess Tools, Cell Therapy
Scalable MSC Manufacturing Matters in a Rapid Response to COVID-19 March 13, 2020 Biomanufacturing, Cell Therapy, Corporate, COVID-19
hUC-MSC Exhibit Robust Proliferation in 3D Bioreactor System January 02, 2020 Biomanufacturing, Cell Therapy
Opportunities for BioManufacturing Sciences to Accelerate Upscaled Mesenchymal Stem Cell Manufacturing… June 15, 2017 Biomanufacturing
Enabling a New Paradigm in hMSC Suspension Bioreactor Cultures August 12, 2015 Biomanufacturing, Bioprocess Tools
